TL;DR CNBC

2024-04-30 13:48:23

FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic

NEGATIVE
TEVA-IL, NVO, NVS, GSK, AZN, AMPH, NOVO.B-DK, NOV.N-CH, TEVA, GSK-GB,